MarketsDr Reddy’s Lab Shares Rise 4% On Pact With Alvotech For Biosimilar DevelopmentBY Outlook Business Desk
CorporateSanofi Calls Report of Insulin Brand Divestment "Unfounded, Incorrect"BY Outlook Business Desk
MarketsStocks To Watch: Dr Reddy's, JSW Energy, PB Fintech And Others In NewsBY Outlook Business Desk
NewsStocks To Watch On 20 July: Dr Reddy’s, Reliance, Federal Bank, Others In NewsBY Outlook Business Desk
NewsEris Lifesciences Acquires 9 Dermatology Brands From Dr Reddy’s For Rs 275 CroreBY Press Trust of India
NewsDr Reddy's Acquires Mayne Pharma's USA Prescription Portfolio For $105 MillionBY Press Trust of India
NewsForex Tailwinds, New Product Launches Drive Dr Reddy’s PAT Up By 77% At Rs 1,247 Crore In Q3BY Press Trust of India
NewsDCGI Grants Approval To Single-Shot Sputnik Light Covid Vaccine For Emergency Use: Dr Reddy'sBY PTI
